About the Data
Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of general and children’s medical-surgical hospitals that report adverse drug events externally (e.g. to FDA, Medwatch, Institute for Safe Medication Practices, manufacturer)
Number of general and children’s medical-surgical hospitals
From the 2009 National Survey of Pharmacy Practice in Hospital Care Settings:
Does your hospital report adverse drug events externally (e.g., FDA, Medwatch, ISMP, manufacturer)?
For this objective, an adverse drug event is an injury resulting from the use of, or not using, a needed medication. Adverse drug events include both adverse drug reactions and medication errors, including both errors of commission and omission, that result in adverse clinical outcomes.
General and children’s medical-surgical hospitals were stratified by the size of the hospital (number of staffed beds), then sampled randomly. The sample focused on inpatient settings, rather than ambulatory settings. Specialty, federal, and VA hospitals were excluded from the sampling frame. The pharmacy directors of sampled hospitals were surveyed by mail.
Hospitals were counted as reporting adverse drug events externally if they reported to FDA, Medwatch, Institute for Safe Medication Practices, or the manufacturer.
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
Additional resources about the objective
- Farley DO, Haviland A, Champagne S, et. Al Berdahl TA. Adverse-Event-Reporting Practices by U.S. Hospitals: Results of a National Survey. Qual Saf Health Care 2008, Dec; 17(6): 416-423.
- Pedersen, CA, Schneider, PJ, Scheckelhoff, DJ. ASHP National Survey of Pharmacy Practice in Hospital Settings: Monitoring and Patient Education-2006. Am J Health-Syst Pharm 2007 Mar; 64.
- Pedersen, CA, Schneider, PJ, Scheckelhoff, DJ. ASHP National Survey of Pharmacy Practice in Hospital Settings: Monitoring and Patient Education-2012. Am J Health-Syst Pharm 2013 May; 70.